Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia

J Child Adolesc Psychopharmacol. 2005 Dec;15(6):844-5. doi: 10.1089/cap.2005.15.844.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Adolescent
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Clozapine / administration & dosage
  • Clozapine / adverse effects
  • Combined Modality Therapy
  • Electroconvulsive Therapy*
  • Humans
  • Injections, Intramuscular
  • Male
  • Methotrimeprazine / administration & dosage
  • Methotrimeprazine / adverse effects
  • Neuroleptic Malignant Syndrome / diagnosis*
  • Neuroleptic Malignant Syndrome / therapy
  • Recurrence
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Methotrimeprazine
  • Clozapine
  • Risperidone